Annual Cash & Cash Equivalents
$43.65 M
+$33.46 M+328.30%
December 31, 2023
Summary
- As of February 8, 2025, APYX annual cash & cash equivalents is $43.65 million, with the most recent change of +$33.46 million (+328.30%) on December 31, 2023.
- During the last 3 years, APYX annual cash & cash equivalents has risen by +$1.74 million (+4.14%).
- APYX annual cash & cash equivalents is now -25.78% below its all-time high of $58.81 million, reached on December 31, 2019.
Performance
APYX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$28.01 M
-$4.67 M-14.28%
September 30, 2024
Summary
- As of February 8, 2025, APYX quarterly cash and cash equivalents is $28.01 million, with the most recent change of -$4.67 million (-14.28%) on September 30, 2024.
- Over the past year, APYX quarterly cash and cash equivalents has dropped by -$9.27 million (-24.86%).
- APYX quarterly cash and cash equivalents is now -58.41% below its all-time high of $67.36 million, reached on June 30, 2019.
Performance
APYX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
APYX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +328.3% | -24.9% |
| 3 y3 years | +4.1% | -9.3% |
| 5 y5 years | +163.0% | -55.0% |
APYX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +328.3% | -35.8% | +174.8% |
| 5 y | 5-year | -25.8% | +328.3% | -52.4% | +174.8% |
| alltime | all time | -25.8% | >+9999.0% | -58.4% | >+9999.0% |
Apyx Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.01 M(-14.3%) |
| Jun 2024 | - | $32.68 M(-12.3%) |
| Mar 2024 | - | $37.28 M(-14.6%) |
| Dec 2023 | $43.65 M(+328.3%) | $43.65 M(+97.2%) |
| Sep 2023 | - | $22.13 M(+19.8%) |
| Jun 2023 | - | $18.48 M(+13.7%) |
| Mar 2023 | - | $16.25 M(+59.5%) |
| Dec 2022 | $10.19 M(-67.0%) | $10.19 M(-31.3%) |
| Sep 2022 | - | $14.83 M(-26.1%) |
| Jun 2022 | - | $20.06 M(-23.5%) |
| Mar 2022 | - | $26.23 M(-15.0%) |
| Dec 2021 | $30.87 M(-26.4%) | $30.87 M(-0.1%) |
| Sep 2021 | - | $30.90 M(-10.9%) |
| Jun 2021 | - | $34.67 M(-12.3%) |
| Mar 2021 | - | $39.54 M(-5.7%) |
| Dec 2020 | $41.91 M(-28.7%) | $41.91 M(-3.7%) |
| Sep 2020 | - | $43.54 M(-5.7%) |
| Jun 2020 | - | $46.16 M(-10.2%) |
| Mar 2020 | - | $51.38 M(-12.6%) |
| Dec 2019 | $58.81 M(+254.4%) | $58.81 M(-5.6%) |
| Sep 2019 | - | $62.27 M(-7.6%) |
| Jun 2019 | - | $67.36 M(+107.8%) |
| Mar 2019 | - | $32.41 M(+95.3%) |
| Dec 2018 | $16.60 M(+66.8%) | $16.60 M(-59.2%) |
| Sep 2018 | - | $40.66 M(+416.4%) |
| Jun 2018 | - | $7.88 M(-9.5%) |
| Mar 2018 | - | $8.70 M(-12.5%) |
| Dec 2017 | $9.95 M(-31.2%) | $9.95 M(+5.7%) |
| Sep 2017 | - | $9.41 M(-8.6%) |
| Jun 2017 | - | $10.29 M(-10.6%) |
| Mar 2017 | - | $11.51 M(-20.4%) |
| Dec 2016 | $14.46 M(+22.5%) | $14.46 M(+55.0%) |
| Sep 2016 | - | $9.33 M(+0.1%) |
| Jun 2016 | - | $9.32 M(-1.4%) |
| Mar 2016 | - | $9.46 M(-19.9%) |
| Dec 2015 | $11.80 M(+105.9%) | $11.80 M(-10.6%) |
| Sep 2015 | - | $13.20 M(-6.3%) |
| Jun 2015 | - | $14.09 M(-8.5%) |
| Mar 2015 | - | $15.40 M(+168.6%) |
| Dec 2014 | $5.73 M(-27.7%) | $5.73 M(-6.6%) |
| Sep 2014 | - | $6.13 M(+10.0%) |
| Jun 2014 | - | $5.58 M(-4.1%) |
| Mar 2014 | - | $5.82 M(-26.6%) |
| Dec 2013 | $7.92 M(+90.4%) | $7.92 M(+216.8%) |
| Sep 2013 | - | $2.50 M(-2.2%) |
| Jun 2013 | - | $2.56 M(-32.0%) |
| Mar 2013 | - | $3.76 M(-9.6%) |
| Dec 2012 | $4.16 M(-14.7%) | $4.16 M(-7.3%) |
| Sep 2012 | - | $4.49 M(-9.9%) |
| Jun 2012 | - | $4.98 M(+21.0%) |
| Mar 2012 | - | $4.12 M(-15.6%) |
| Dec 2011 | $4.88 M | $4.88 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $5.41 M(-5.4%) |
| Jun 2011 | - | $5.71 M(+28.3%) |
| Mar 2011 | - | $4.45 M(+16.4%) |
| Dec 2010 | $3.83 M(+77.6%) | $3.83 M(+44.4%) |
| Sep 2010 | - | $2.65 M(-21.3%) |
| Jun 2010 | - | $3.37 M(+27.6%) |
| Mar 2010 | - | $2.64 M(+22.5%) |
| Dec 2009 | $2.15 M(-16.0%) | $2.15 M(-26.3%) |
| Sep 2009 | - | $2.92 M(-6.1%) |
| Jun 2009 | - | $3.12 M(+22.8%) |
| Mar 2009 | - | $2.54 M(-1.1%) |
| Dec 2008 | $2.56 M(-27.5%) | $2.56 M(-37.2%) |
| Sep 2008 | - | $4.08 M(+8.1%) |
| Jun 2008 | - | $3.78 M(+7.3%) |
| Mar 2008 | - | $3.52 M(-0.4%) |
| Dec 2007 | $3.53 M(+19.7%) | $3.53 M(+34.0%) |
| Sep 2007 | - | $2.64 M(+5.4%) |
| Jun 2007 | - | $2.50 M(-20.0%) |
| Mar 2007 | - | $3.12 M(+5.8%) |
| Dec 2006 | $2.95 M(+128.0%) | $2.95 M(+27.9%) |
| Sep 2006 | - | $2.31 M(+22.0%) |
| Jun 2006 | - | $1.89 M(+15.9%) |
| Mar 2006 | - | $1.63 M(+26.1%) |
| Dec 2005 | $1.30 M(-43.6%) | $1.30 M(+2.2%) |
| Sep 2005 | - | $1.27 M(+16.2%) |
| Jun 2005 | - | $1.09 M(-49.1%) |
| Mar 2005 | - | $2.14 M(-6.7%) |
| Dec 2004 | $2.29 M(+649.7%) | $2.29 M(+29.6%) |
| Sep 2004 | - | $1.77 M(+101.7%) |
| Jun 2004 | - | $878.30 K(+122.3%) |
| Mar 2004 | - | $395.10 K(+29.1%) |
| Dec 2003 | $306.10 K(-19.3%) | $306.10 K(-47.0%) |
| Sep 2003 | - | $577.50 K(-14.2%) |
| Jun 2003 | - | $672.90 K(+94.1%) |
| Mar 2003 | - | $346.70 K(-8.6%) |
| Dec 2002 | $379.20 K(-34.4%) | $379.20 K(-17.9%) |
| Sep 2002 | - | $461.80 K(+101.3%) |
| Jun 2002 | - | $229.40 K(-27.2%) |
| Mar 2002 | - | $315.30 K(-45.5%) |
| Dec 2001 | $578.40 K(+107.5%) | $578.40 K(+43.7%) |
| Sep 2001 | - | $402.50 K(-4.5%) |
| Jun 2001 | - | $421.60 K(+34.5%) |
| Mar 2001 | - | $313.40 K(+12.5%) |
| Dec 2000 | $278.70 K(-32.9%) | $278.70 K(-36.2%) |
| Sep 2000 | - | $436.90 K(-24.6%) |
| Jun 2000 | - | $579.70 K(-2.6%) |
| Mar 2000 | - | $595.30 K |
| Dec 1999 | $415.10 K(+48.9%) | - |
| Dec 1998 | $278.70 K(+478.2%) | - |
| Dec 1997 | $48.20 K(-60.1%) | - |
| Dec 1996 | $120.90 K(-27.1%) | - |
| Dec 1995 | $165.80 K | - |
FAQ
- What is Apyx Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Apyx Medical?
- What is Apyx Medical annual cash & cash equivalents year-on-year change?
- What is Apyx Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Apyx Medical?
- What is Apyx Medical quarterly cash and cash equivalents year-on-year change?
What is Apyx Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of APYX is $43.65 M
What is the all time high annual cash & cash equivalents for Apyx Medical?
Apyx Medical all-time high annual cash & cash equivalents is $58.81 M
What is Apyx Medical annual cash & cash equivalents year-on-year change?
Over the past year, APYX annual cash & cash equivalents has changed by +$33.46 M (+328.30%)
What is Apyx Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of APYX is $28.01 M
What is the all time high quarterly cash and cash equivalents for Apyx Medical?
Apyx Medical all-time high quarterly cash and cash equivalents is $67.36 M
What is Apyx Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, APYX quarterly cash and cash equivalents has changed by -$9.27 M (-24.86%)